Wonder Fibromats Limited (WFL)

Overview

Wellfully Limited is a company engaged in the niche area of transdermal drug delivery technology, focusing on the development and commercialization of its proprietary Dermaportation and Electroporation Therapy (ETP) technologies. These innovative platforms are designed to enhance the delivery of drugs through the skin, providing a potentially more efficient and patient-friendly method compared to traditional administration routes. The firm operates through two main segments: Dermaportation Drug Delivery Technology and Devices, reflecting its dual focus on technology development as well as the creation of physical delivery devices. Initially founded as OBJ Limited, the company transitioned to its current identity in September 2020, signaling a new chapter focused more closely on its core competencies in drug delivery systems. With a history stretching back to 1992, Wellfully Limited is headquartered in Leederville, Australia, and serves a diverse range of sectors including pharmaceuticals, cosmetics and skincare, and consumer healthcare. This broad market approach indicates Wellfully's ambition to integrate its technologies across a variety of applications, strengthening its position in each sector by offering innovative solutions to common delivery challenges.

Products and Services

Wellfully Limited offers a range of products and services centered around its pioneering drug delivery technologies. These offerings are tailored to meet the needs of various sectors, including pharmaceuticals, cosmetics, and consumer healthcare. The company's commitment to innovation is reflected in its unique products and collaborative efforts.

• Dermaportation Drug Delivery Technology: This technology leverages the natural processes of the skin to enhance the delivery of active pharmaceutical ingredients (APIs) and beauty compounds. It is designed to improve the efficacy and efficiency of skin applications, offering a non-invasive alternative to traditional drug delivery methods. Wellfully's work in this area aims to revolutionize how medications and skincare products are formulated and applied, promising better outcomes for users.
• Devices: In parallel with its focus on transdermal delivery technologies, Wellfully is also involved in the design and development of innovative devices aimed at facilitating the application of its Dermaportation technology. These devices are integral to the overall effectiveness of the Dermaportation method, ensuring that compounds are delivered in the most efficient manner possible.
• REDUIT: This brand reflects Wellfully's venture into the consumer market, offering a range of products that utilize the company's proprietary technologies to enhance skincare and wellness routines. REDUIT products are designed to optimize the absorption of nutrients and active ingredients, providing superior results with minimal effort.
• SWISSWELL: Under the SWISSWELL brand, Wellfully explores the intersection of technology and luxury skincare. These products are formulated to meet the highest standards of efficacy and quality, embodying the company's commitment to excellence in skincare innovation.
• Third-Party Collaborations: Recognizing the value of partnership in driving technological advancement, Wellfully engages in collaborations with third-party entities. These partnerships extend the reach of its Dermaportation and ETP technologies, fostering their application across a wider array of products and sectors. Such collaborations not only showcase the versatility of Wellfully's technologies but also contribute to the growth and refinement of its offerings.